Given that minor changes in the surface expression of the co-receptor are expected to have significant effects on responses to autoantigen and in cancer immunotherapy, it is important to understand the mechanisms that determine the expression of CTLA-4 on T-cells. The gene discussed is CTLA4; the disease is cancer.